Home > Financial Ratios > AJANTA PHARMA

AJANTA PHARMA
EV/Core EBITDA

    Back to All Ratios
AJANTA PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for AJANTA PHARMA
Please provide your vote to see the results

AJANTA PHARMA Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EV/Core EBITDA(x) 22.4224.0322.3216.8914.58

What is the latest EV/Core EBITDA ratio of AJANTA PHARMA ?

The latest EV/Core EBITDA ratio of AJANTA PHARMA is 22.42 based on Mar2026 Consolidated results.
Year EV/Core EBITDA
Mar202622.42
Mar202524.03
Mar202422.32
Mar202316.89
Mar202214.58

How is EV/Core EBITDA of AJANTA PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2026 22.42
-6.70
Mar2025 24.03
7.66
Mar2024 22.32
32.15
Mar2023 16.89
15.84
Mar2022 14.58 -

Other Financial Ratios of AJANTA PHARMA


Compare EV/Core EBITDA ratio of peers of AJANTA PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AJANTA PHARMA ₹44,793.1 Cr 2.9% 2.1% 37.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹451,339.0 Cr -2.7% -3.7% 20.3% Stock Analytics
DIVIS LABORATORIES ₹254,068.0 Cr 3.7% 15.7% 51% Stock Analytics
TORRENT PHARMACEUTICALS ₹188,767.0 Cr -0.8% 1% 36.2% Stock Analytics
CIPLA ₹111,804.0 Cr -2.1% -5.2% -11.6% Stock Analytics
DR REDDYS LABORATORIES ₹96,113.4 Cr -0.8% -0.5% -9.3% Stock Analytics


AJANTA PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AJANTA PHARMA

2.9%

2.1%

37.4%

SENSEX

-1.8%

-3.7%

-5.7%


You may also like the below Video Courses